Monte Rosa Therapeutics (GLUE) Stock Chart & Stock Price History $4.92 -0.13 (-2.57%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Monte Rosa Therapeutics Stock Price Performance The Monte Rosa Therapeutics (GLUE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 18.27%, with a year-to-date return of -29.11%. In the past month, the stock has increased 15.22%, reflecting recent market activity. As of the latest close, Monte Rosa Therapeutics traded at $5.05 with a market cap of $310.63 million and volume of 531,790 shares. Receive GLUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.80%1 Month Performance+15.22%3 Month Performance-25.90%Year-To-Date Performance-29.11%1 Year Performance+18.27% GLUE Stock Chart for Thursday, June, 12, 2025 GLUE Chart by TradingView Monte Rosa Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$5.05$4.92-2.57%$5.03$4.87413,498 shs$302.63 million06/11/2025$5.08$5.05-0.59%$5.26$5.03531,790 shs$310.63 million06/10/2025$4.92$5.08+3.25%$5.20$4.97278,176 shs$312.47 million06/09/2025$5.01$4.92-1.80%$5.19$4.82269,921 shs$302.63 million06/06/2025$4.62$5.01+8.44%$5.04$4.61454,336 shs$308.17 million06/05/2025$4.61$4.62+0.22%$4.73$4.51507,307 shs$284.18 million06/04/2025$4.64$4.61-0.65%$4.77$4.56229,652 shs$283.56 million06/03/2025$4.50$4.64+3.11%$4.82$4.35772,294 shs$285.41 million06/02/2025$4.14$4.50+8.70%$4.58$4.09646,185 shs$276.80 million05/30/2025$4.23$4.14-2.13%$4.21$3.90465,211 shs$254.65 million Get the Latest News and Ratings for GLUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$4.06$4.23+4.19%$4.30$4.00872,099 shs$260.19 million05/28/2025$3.99$4.06+1.75%$4.23$3.91711,536 shs$249.73 million05/27/2025$3.97$3.99+0.50%$4.06$3.90372,667 shs$245.43 million05/26/2025$3.97$3.97$4.07$3.95515,620 shs$244.20 million05/23/2025$4.05$3.97-1.98%$4.07$3.95515,620 shs$244.20 million05/22/2025$4.01$4.05+1.00%$4.15$3.97320,319 shs$249.12 million05/21/2025$4.16$4.01-3.61%$4.13$3.84556,623 shs$246.66 million05/20/2025$4.11$4.16+1.22%$4.20$4.01306,194 shs$255.88 million05/19/2025$3.98$4.11+3.27%$4.25$4.01463,226 shs$252.81 million05/16/2025$3.87$3.98+2.84%$4.05$3.81421,565 shs$244.81 million05/15/2025$3.70$3.87+4.59%$3.88$3.51369,322 shs$238.04 million05/14/2025$4.04$3.70-8.42%$4.13$3.70318,555 shs$227.59 million05/13/2025$4.27$4.04-5.39%$4.34$4.04371,845 shs$248.50 million05/12/2025$4.11$4.27+3.89%$4.43$4.08389,170 shs$262.65 million Related Companies AUPH Stock Price Chart ELVN Stock Price Chart WVE Stock Price Chart MLYS Stock Price Chart RCUS Stock Price Chart CVAC Stock Price Chart SYRE Stock Price Chart AKBA Stock Price Chart PAHC Stock Price Chart SNDX Stock Price Chart Receive GLUE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GLUE) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monte Rosa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monte Rosa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GLUE Stock Free GLUE Stock Alerts